The pro-inflammatory cytokines (IL-12, IL-23, IFNα, and IFNβ) were measured at pre- and post-treatment time points after the completion of the anti-tuberculosis treatment (ATT) in TBL individuals (Figure 2). Here, IFNB1 is linked to tuberculosis.